Bolt Biotherapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.33
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.60
|
0.00
|
0.60
|
100.00%
|
|
2022-12-31
|
-0.59
|
0.00
|
0.59
|
100.00%
|
|
2022-09-30
|
-0.56
|
-0.58
|
-0.02
|
-3.57%
|
|
2022-06-30
|
-0.68
|
-0.61
|
0.07
|
10.29%
|
|
2022-03-31
|
-0.72
|
-0.64
|
0.08
|
11.11%
|
|
2021-12-31
|
-0.82
|
-0.73
|
0.09
|
10.98%
|
|
2021-09-30
|
-0.65
|
-0.63
|
0.02
|
3.08%
|
|
2021-06-30
|
-0.43
|
-0.64
|
-0.21
|
-48.84%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.83
|
|
2021-12-31
|
-3.14
|
|
2020-12-31
|
-19.43
|
|
2019-12-31
|
-11.85
|
|
2018-12-31
|
-3.59
|